Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.
Video Forum: Christine Baeder, Teva USA
Latest
CRN opposes California protein powder bill
According to CRN, SB 1033 adopts misguided policies that impose burdens beyond federal rules and send alarmist messages about nonexistent harms.
FMI releases statement on January CPI food price numbers
“The food industry remains committed to keeping prices as low as possible for households across the country.”
Fresh Thyme Market reaffirms 2026 focus on health, hunger relief, and affordability
The grocer is extending key partnerships, reaffirming the commitment to invest in the well-being of the communities it serves
Save A Lot shows biggest customer satisfaction gain in recent national study
Save A Lot’s score jumped 4% to 78, marking the biggest gain in the supermarket sector year over year